Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy
PDF
Cite
Share
Request
Chest Imaging - Original Article
P: 195-202
July 2018

Dynamic contrast-enhanced MRI for advanced esophageal cancer response assessment after concurrent chemoradiotherapy

Diagn Interv Radiol 2018;24(4):195-202
1. Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
2. Department of Radiotherapy, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
No information available.
No information available
Received Date: 10.10.2017
Accepted Date: 12.03.2018
PDF
Cite
Share
Request

ABSTRACT

PURPOSE:

We aimed to evaluate the treatment response of patients with esophageal cancer after concurrent chemoradiation therapy (CRT) using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI).

METHODS:

This retrospective study included 59 patients with histologically confirmed esophageal squamous cell carcinoma. The patients underwent DCE-MRI before and 4 weeks after CRT. Patients with complete response were defined as the CR group; partial response, stable disease, and progressive disease patients were defined as the non-CR group. DCE-MRI parameters (Ktrans, Ve, and Kep) were measured and compared between pre- and post-CRT in the CR and non-CR groups, respectively. Pre-CRT and post-CRT parameters were used to calculate the absolute change and the ratio of change. DCE-MRI parameters were compared between the CR and non-CR groups. Receiver operating characteristic (ROC) curves were used to verify diagnostic performance.

RESULTS:

Patients with higher T-stage esophageal cancer might present with poorer response. After CRT, the Ktrans and Kep values significantly decreased in the CR group, whereas only Kep value decreased in the non-CR group. The post-Ktrans and post-Kep values were observed to be significantly lower in the CR group than in the non-CR group. The absolute change and ratio of change of both Ktrans and Kep were higher in the CR group than in the non-CR group. Based on ROC analysis, the ratio of change in Ktrans was the best parameter to assess treatment response (AUC= 0.840).

CONCLUSION:

DCE-MRI parameters are valuable in predicting and assessing concurrent CRT response for advanced esophageal cancer.